Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Companion Diagnostics
 More »

  • FDA Approves Roche EGFR Mutation CDx for NSCLC
    and Radiological Health, in a statement. "Companion diagnostics play an important role in determining which therapies are the safest and most effective for a particular patient." ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    Following are three lists depicting recent activity in the development of companion diagnostics: a rundown of all 15 FDA-approved companion diagnostics, as listed on the "Companion ...
    5-9-2013
  • Cancer Diagnostics, Pushing the Boundaries
    They report "significant need for better biomarkers and companion diagnostics," with biomarkers and diagnostics "being used earlier in development, but still under-utilized." ...
    5-8-2013
  • Algeta Expands Cancer Drug Collaboration with Lumiphore
    Algeta also has the right to develop in vivo companion diagnostics for radio-imaging. Financial terms were not disclosed. The companies originally signed an option/license ...
    5-2-2013
  • Personalized Medicine: The Societal Perspective
    We have discussed the challenges in translation, development of routine companion diagnostics and pricing and reimbursing , but there is another challenge: how do we integrate ...
    4-8-2013
  • Personalized Medicine: Health Economic Aspects
    medicine. [AlienForce - Fotolia.com] From the previous chapter's discussion of turning biomarkers into companion diagnostics, we now shift to a discussion of healthcare. ...
    4-2-2013
  • Development and Evolution of PCR
    ... The first clinical molecular diagnostics in-vitro diagnostic (IVD) test was a ... In some cases, the assay is co-developed with the drug and is known as a companion ...
    4-1-2013
  • Exploiting Folate Pathways to Treat Cancer
    ... CSO Number of Employees: 75 Focus : Endocyte develops targeted small molecule drug conjugates and companion imaging diagnostics to treat cancer and other diseases. | Carol Potera
    4-1-2013
  • Myriad to Use New HRD Test with PharmaMar's DNA-Damaging Drug
    PharmaMar on this exciting new companion diagnostic program," said Peter Meldrum, president and CEO of Myriad Genetics. Molecular diagnostics company Myriad Genetics signed an ...
    3-27-2013
  • Personalized Medicine: From Biomarkers to Companion Diagnostics
    The industry needs time to bring diagnostic and therapeutic research together, and regulation should leave room to develop companion diagnostics in various business models instead ...
    3-26-2013
  • PrimeraDx on Quest for New Companion Dx
    The ICEPlex system received the CE mark in September of last year and was the focus of a similar companion diagnostics collaboration with Eli Lilly back in June . The companies ...
    3-26-2013
  • Personalized Medicine: Translation of Concepts
    ... That is one of the reasons why oncology is a front runner in personalised medicine with several tissue based companion diagnostics. On the other hand, still very little is known ...
    3-19-2013
  • Rise of Cell-Based Immunotherapy
    There is much excitement in the growth and evolution of the personalized medicine field driven in large part by the approvals of 15 companion diagnostics-therapeutics combinations ...
    3-1-2013
  • Qiagen, Lilly Take on Companion Diagnostics
    Qiagen and Eli Lilly have teamed up to develop and commercialize companion diagnostics for pairing with Lilly investigational and approved medicines across all therapeutic areas. ...
    2-14-2013
  • Unlocking Biomarkers' Full Potential
    ... But it is very clear that to be successful in the clinic, the biomarkers and the assays need to be of low complexity. Of the 10 to 12 companion diagnostics that have been approved ...
    2-1-2013

  • Journal Articles

  • Precision Medicine: Generating Real-World Evidence for Companion...
    Elizabeth J. Horn, Sharon F. Terry
    Genetic Testing and Molecular Biomarkers
    Precision Medicine: Generating Real-World Evidence for Companion Diagnostics Genetic Testing and Molecular Biomarkers

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll